We conducted a phase 3, double-blind, randomized, placebo-controlled trial in which patients who had had three or more episodes of C. difficile infection (inclusive of the qualifying acute episode) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback